Literature DB >> 31698449

Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome.

Yoshihiro Fujimura1,2, Bernhard Lämmle3,4, Saori Tanabe5, Kazuya Sakai2, Toshiyuki Kimura5, Koichi Kokame6, Toshiyuki Miyata6,7, Yukihiro Takahashi1, Shigeki Taniguchi8, Masanori Matsumoto2.   

Abstract

Entities:  

Year:  2019        PMID： 31698449      PMCID： PMC6855110          DOI： 10.1182/bloodadvances.2019000601

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  21 in total

1.  Acquired von Willebrand disease in an infant. Resolution by interventional occlusion of patent ductus arteriosus.

Authors:  R Rauch; U Budde; M Girisch; J Klinge; M Hofbeck
Journal:  Thromb Res       Date:  2001-06-01       Impact factor: 3.944

2.  Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency.

Authors:  I SCHULMAN; M PIERCE; A LUKENS; Z CURRIMBHOY
Journal:  Blood       Date:  1960-07       Impact factor: 22.113

3.  Atypical congenital haemolytic anaemia.

Authors:  J V DACIE; P L MOLLISON; N RICHARDSON; J G SELWYN; L SHAPIRO
Journal:  Q J Med       Date:  1953-01

4.  Thrombotic thrombocytopenic purpura in a neonatal infant.

Authors:  L A Monnens; R J Retera
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

5.  Cardiopulmonary Adaptation During First Day of Life in Human Neonates.

Authors:  Amish Jain; Adel Mohamed; Brian Kavanagh; Prakesh S Shah; Bart C W Kuipers; Afif El-Khuffash; Luc Mertens; Robert P Jankov; Patrick J McNamara
Journal:  J Pediatr       Date:  2018-05-24       Impact factor: 4.406

6.  Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Bart Van Overmeire; Karel Allegaert; Alexandra Casaer; Christian Debauche; Wim Decaluwé; Ann Jespers; Joost Weyler; Inge Harrewijn; Jean-Paul Langhendries
Journal:  Lancet       Date:  2004 Nov 27-Dec 3       Impact factor: 79.321

Review 7.  Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.

Authors:  Y Fujimura; M Matsumoto; A Isonishi; H Yagi; K Kokame; K Soejima; M Murata; T Miyata
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.

Authors:  Saori Tanabe; Hideo Yagi; Toshiyuki Kimura; Ayami Isonishi; Seiji Kato; Yoko Yoshida; Masaki Hayakawa; Masanori Matsumoto; Shinsuke Ohtaki; Yukihiro Takahashi; Yoshihiro Fujimura
Journal:  Int J Hematol       Date:  2012-11-28       Impact factor: 2.490

10.  The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.

Authors:  Hendrika A van Dorland; Magnus Mansouri Taleghani; Kazuya Sakai; Kenneth D Friedman; James N George; Ingrid Hrachovinova; Paul N Knöbl; Anne Sophie von Krogh; Reinhard Schneppenheim; Isabella Aebi-Huber; Lukas Bütikofer; Carlo R Largiadèr; Zuzana Cermakova; Koichi Kokame; Toshiyuki Miyata; Hideo Yagi; Deirdra R Terrell; Sara K Vesely; Masanori Matsumoto; Bernhard Lämmle; Yoshihiro Fujimura; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941
View more
  4 in total

1.  First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene.

Authors:  Sheng-Chieh Chou; Dong-Tasmn Lin; Ching-Yeh Lin; Ying-Chih Huang; Han-Ni Hsieh; Ming-Ching Shen
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

Review 2.  COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm.

Authors:  Yoshihiro Fujimura; Linda Z Holland
Journal:  Int J Hematol       Date:  2022-03-22       Impact factor: 2.319

3.  Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Jessica A Reese; Samiksha Gupta; James N George
Journal:  Blood Adv       Date:  2022-02-08

4.  Early indicators of neonatal-onset hereditary thrombotic thrombocytopenia purpura.

Authors:  Jing Liu; Yuelun Zhang; Zhuo Li; Zhenghong Li; Lejia Zhang; Shan Jian; Changyan Wang; Yuqing Song; Zichao Lv; Xiaoyan Tang; Lijuan Gou; Juan Xiao
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.